These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 33640110)
1. Journal club: "Impact of a C. difficile infection (CDI) reduction bundle and its components on CDI diagnosis and prevention". Bodily-Bartrum M; Adeyeye AA Am J Infect Control; 2021 Mar; 49(3):403-404. PubMed ID: 33640110 [No Abstract] [Full Text] [Related]
2. Impact of a C. difficile infection (CDI) reduction bundle and its components on CDI diagnosis and prevention. Blanco N; Robinson GL; Heil EL; Perlmutter R; Wilson LE; Brown CH; Heavner MS; Nadimpalli G; Lemkin D; Morgan DJ; Leekha S Am J Infect Control; 2021 Mar; 49(3):319-326. PubMed ID: 33640109 [TBL] [Abstract][Full Text] [Related]
3. Prevention of Infection due to Clostridium (Clostridioides) difficile. Krishna A; Chopra T Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229 [TBL] [Abstract][Full Text] [Related]
4. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship. Savage TJ; Sandora TJ J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402 [TBL] [Abstract][Full Text] [Related]
5. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530 [TBL] [Abstract][Full Text] [Related]
6. Impact of no-touch ultraviolet light room disinfection systems on Clostridioides difficile infections. McMullen K; Guth RM; Wood H; Mueller C; Dunn G; Wade R; Siddiqui A; Dubberke ER; Woeltje KF; Warren DK Am J Infect Control; 2021 May; 49(5):646-648. PubMed ID: 32860846 [TBL] [Abstract][Full Text] [Related]
7. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data. Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068 [TBL] [Abstract][Full Text] [Related]
8. The impact of an electronic medical record nudge on reducing testing for hospital-onset Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members. Khanafer NL; Fitzpatrick F; Barbut F; Krutova M; Davies K; Guery B; Vanhems P Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):785-789. PubMed ID: 38332395 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study. DiDiodato G; McArthur L PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536 [TBL] [Abstract][Full Text] [Related]
13. Detection, treatment, and prevention of Clostridium difficile infection. McCollum DL; Rodriguez JM Clin Gastroenterol Hepatol; 2012 Jun; 10(6):581-92. PubMed ID: 22433924 [TBL] [Abstract][Full Text] [Related]
14. [Interpretation of group standard for Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698 [TBL] [Abstract][Full Text] [Related]
15. Holding firm: Use of clinical correlation to improve Clostridioides difficile testing. Baghdadi J; Ganz DA; Chumpia M; Chang ET; de Peralta SS Am J Infect Control; 2020 Sep; 48(9):1104-1107. PubMed ID: 31862165 [TBL] [Abstract][Full Text] [Related]
16. Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities. Toth DJA; Keegan LT; Samore MH; Khader K; O'Hagan JJ; Yu H; Quintana A; Swerdlow DL Vaccine; 2020 Aug; 38(37):5927-5932. PubMed ID: 32703744 [TBL] [Abstract][Full Text] [Related]
17. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients. Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250 [TBL] [Abstract][Full Text] [Related]
18. The Impact of Clinical Decision Support Alerts on Clostridioides difficile Testing: A Systematic Review. Dunn AN; Radakovich N; Ancker JS; Donskey CJ; Deshpande A Clin Infect Dis; 2021 Mar; 72(6):987-994. PubMed ID: 32060501 [TBL] [Abstract][Full Text] [Related]
19. It Is Not about the Assay: Preanalytical Screening Is the Key to Reducing Chow SK; Naderpour A; Van Enk J J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429255 [No Abstract] [Full Text] [Related]
20. Clostridium difficile control measures: current and future methods for prevention. Mejia-Chew C; Dubberke ER Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]